Balance Sheet Data

Clovis Oncology, Inc. (CLVS)

$0.3438

-0.02 (-4.50%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 563.73520.15296.66240.23143.43788.471,039.251,369.781,805.442,379.66
Total Cash (%)
Account Receivables 8.2115.1634.6630.6033.6737.7149.7065.5186.34113.81
Account Receivables (%)
Inventories 27.5127.0726.5230.7113.6948.7664.2784.71111.65147.17
Inventories (%)
Accounts Payable 15.1528.5232.2426.6927.3144.8259.0877.87102.64135.28
Accounts Payable (%)
Capital Expenditure -4.10-64.24-19.04-8.35-0.31-36.60-48.24-63.59-83.81-110.47
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.